# Foghorn Therapeutics Inc.: Form 8-K, filed Jul 14, 2021

- Company: [Foghorn Therapeutics Inc.](/companies/fhtx.md) (CIK 1822462)
- Form: 8-K
- Filed: 2021-07-14
- Accepted by EDGAR: Jul 14, 2021, 08:05 ET
- Period: 2021-07-14
- Accession: 0001628280-21-013802
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1822462/000162828021013802/fhtx-20210714.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1822462/000162828021013802/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1822462/000162828021013802/fhtx-20210714.htm

Filed Jul 14, 2021.
Source: SEC EDGAR, the filing index for accession 0001628280-21-013802. Last ingested by Listed: Nov 9, 2026, 17:27 ET. No prices; not investment advice.